0001209191-23-051259.txt : 20231002 0001209191-23-051259.hdr.sgml : 20231002 20231002201614 ACCESSION NUMBER: 0001209191-23-051259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230928 FILED AS OF DATE: 20231002 DATE AS OF CHANGE: 20231002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 231301287 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-28 0 0001720580 Adicet Bio, Inc. ACET 0001340875 Schor Chen C/O ADICET BIO, INC. 200 BERKELEY STREET, 19TH FLOOR BOSTON MA 02116 1 1 0 0 President & CEO 0 Common Stock 2023-09-28 4 S 0 5500 1.42 D 37969 I See Footnote Common Stock 2023-09-28 4 P 0 5500 1.42 A 182469 D Common Stock 2023-09-29 4 S 0 5500 1.3601 D 176969 D Common Stock 2023-10-02 4 P 0 5500 1.3345 A 43469 I See Footnote Common Stock 2023-10-02 4 F 0 23208 1.37 D 153761 D Common Stock 53424 I See Footnote The transactions reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Person will promptly and voluntarily disgorge to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act. Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $1.33 to $1.38, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $1.32 to $1.35, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person. Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee. /s/ Nick Harvey, Attorney-in-Fact 2023-10-02